• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核因子 kappa B p50 亚基和皮质肌动蛋白作为鉴别角化棘皮瘤和分化良好的鳞状细胞癌的标志物。

The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.

机构信息

Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.

出版信息

Clin Exp Dermatol. 2011 Oct;36(7):788-92. doi: 10.1111/j.1365-2230.2011.04118.x. Epub 2011 Aug 25.

DOI:10.1111/j.1365-2230.2011.04118.x
PMID:21883393
Abstract

BACKGROUND

Distinguishing keratoacanthoma (KA) from well-differentiated squamous cell carcinoma (SCC) is sometimes difficult. Recent evidence indicates that the nuclear factor kappa B p50 subunit (p50) and cortactin might be useful to distinguish between these two conditions.

AIM

To verify whether p50 and cortactin are useful differentiation markers to distinguish between subungual KA and well-differentiated SCC.

METHODS

Immunohistochemistry using p50, cortactin and Ki-67 was performed on 20 patients with KA and 20 patients with facial well-differentiated SC. Ki-67 staining was also evaluated and scored.

RESULTS

Both p50 and cortactin had higher levels of expression in KA than in SCC. Both were localized to the basal-cell layer of KA, whereas they were scattered without polarity throughout the SCC lesions. Although the Ki-67 index was not significantly different between KA and SCC, the staining pattern also showed loss of polarity in SCC.

CONCLUSION

p50 and cortactin might be useful makers to distinguish between KA and well-differentiated SCC.

摘要

背景

区分角化棘皮瘤(KA)和分化良好的鳞状细胞癌(SCC)有时较为困难。最近的证据表明,核因子κB p50 亚基(p50)和皮质肌动蛋白可能有助于区分这两种情况。

目的

验证 p50 和皮质肌动蛋白是否可作为区分甲下 KA 和分化良好 SCC 的有用分化标志物。

方法

对 20 例 KA 患者和 20 例面部分化良好 SCC 患者进行 p50、皮质肌动蛋白和 Ki-67 的免疫组织化学检测。还评估和评分了 Ki-67 染色。

结果

p50 和皮质肌动蛋白在 KA 中的表达水平均高于 SCC。p50 和皮质肌动蛋白均定位于 KA 的基底层,而 SCC 病变中的染色则呈散在分布,无极性。尽管 KA 和 SCC 之间的 Ki-67 指数无显著差异,但染色模式也显示 SCC 极性丧失。

结论

p50 和皮质肌动蛋白可能是区分 KA 和分化良好 SCC 的有用标志物。

相似文献

1
The nuclear factor kappa B p50 subunit and cortactin as markers to distinguish between keratoacanthoma and well-differentiated squamous cell carcinoma.核因子 kappa B p50 亚基和皮质肌动蛋白作为鉴别角化棘皮瘤和分化良好的鳞状细胞癌的标志物。
Clin Exp Dermatol. 2011 Oct;36(7):788-92. doi: 10.1111/j.1365-2230.2011.04118.x. Epub 2011 Aug 25.
2
Subungual keratoacanthoma: analysis of cell proliferation and copy number variation of oncogenes compared with periungual squamous cell carcinoma.甲下角化棘皮瘤:与甲周鳞状细胞癌相比,分析细胞增殖和癌基因的拷贝数变异。
Clin Exp Dermatol. 2011 Jan;36(1):57-62. doi: 10.1111/j.1365-2230.2010.03841.x.
3
Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.细胞周期和凋亡调节蛋白在角化棘皮瘤和鳞状细胞癌中的表达
Pathol Res Pract. 2006;202(8):599-607. doi: 10.1016/j.prp.2006.04.004. Epub 2006 Jun 15.
4
VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas.血管细胞黏附分子(CD-106)和细胞间黏附分子(CD-54)可区分角化棘皮瘤与皮肤鳞状细胞癌。
Mod Pathol. 2003 Jan;16(1):8-13. doi: 10.1097/01.MP.0000043520.74056.CD.
5
Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.通过MIB-1免疫组织化学法鉴别表皮角化棘皮瘤和鳞状细胞癌。
Anticancer Res. 2002 Sep-Oct;22(5):3019-23.
6
p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.角化棘皮瘤和鳞状细胞癌中p53癌蛋白表达及增殖指数
Arch Dermatol. 1994 Feb;130(2):181-6.
7
Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.通过角化棘皮瘤和鳞状细胞癌中M30表达评估细胞凋亡。
Coll Antropol. 2008 Jun;32(2):499-504.
8
Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.胰岛素样生长因子2信使核糖核酸结合蛋白-3作为区分皮肤鳞状细胞癌和角化棘皮瘤的标志物
Int J Oncol. 2016 Mar;48(3):1007-15. doi: 10.3892/ijo.2016.3323. Epub 2016 Jan 5.
9
Cytokeratin 10 and Ki-67 nuclear marker expression in keratoacanthoma and squamous cell carcinoma.角蛋白10和Ki-67核标记物在角化棘皮瘤和鳞状细胞癌中的表达
Acta Dermatovenerol Croat. 2004;12(4):251-6.
10
Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers.通过使用凋亡和细胞粘附标记物鉴别角化棘皮瘤与鳞状细胞癌。
Histopathology. 2005 Aug;47(2):170-8. doi: 10.1111/j.1365-2559.2005.02155.x.

引用本文的文献

1
The Pathogenic Effect of Cortactin Tyrosine Phosphorylation in Cutaneous Squamous Cell Carcinoma.皮层肌动蛋白酪氨酸磷酸化在皮肤鳞状细胞癌中的致病作用
In Vivo. 2019 Mar-Apr;33(2):393-400. doi: 10.21873/invivo.11486.